Inovio Pharmaceuticals, Inc.【INO】 営業費用の推移
機能の使い方
|
（単位：千ドル）
|
営業費用
|
前年比（％）
|
|
4Q25
|
17,476
|
-14.7%
|
|
3Q25
|
21,210
|
-22.4%
|
|
2Q25
|
23,084
|
-30.7%
|
|
1Q25
|
25,115
|
-20.2%
|
|
4Q24
|
20,486
|
-25.5%
|
|
3Q24
|
27,347
|
-23.9%
|
|
2Q24
|
33,297
|
-10.7%
|
|
1Q24
|
31,484
|
-28.6%
|
|
4Q23
|
27,496
|
-51.0%
|
|
3Q23
|
35,941
|
-20.0%
|
|
2Q23
|
37,267
|
-64.5%
|
|
1Q23
|
44,067
|
-38.7%
|
|
4Q22
|
56,070
|
-47.3%
|
|
3Q22
|
44,911
|
-25.5%
|
|
2Q22
|
104,921
|
+25.7%
|
|
1Q22
|
71,932
|
+35.9%
|
|
4Q21
|
106,347
|
+204.5%
|
|
3Q21
|
60,244
|
+64.8%
|
|
2Q21
|
83,474
|
+149.6%
|
|
1Q21
|
52,925
|
+99.3%
|
|
4Q20
|
34,920
|
+13.7%
|
|
3Q20
|
36,565
|
+47.3%
|
|
2Q20
|
33,448
|
+18.0%
|
|
1Q20
|
26,559
|
-15.3%
|
|
4Q19
|
30,700
|
-4.1%
|
|
3Q19
|
24,818
|
-13.4%
|
|
2Q19
|
28,336
|
-4.4%
|
|
1Q19
|
31,364
|
-8.5%
|
|
4Q18
|
32,001
|
+1.0%
|
|
3Q18
|
28,643
|
-10.0%
|
|
2Q18
|
29,651
|
-1.3%
|
|
1Q18
|
34,275
|
+6.1%
|
|
4Q17
|
31,675
|
+2.6%
|
|
3Q17
|
31,830
|
-2.8%
|
|
2Q17
|
30,047
|
+23.0%
|
|
1Q17
|
32,310
|
+37.1%
|
|
4Q16
|
30,877
|
+50.9%
|
|
3Q16
|
32,735
|
+60.1%
|
|
2Q16
|
24,430
|
+19.7%
|
|
1Q16
|
23,560
|
+74.1%
|
|
4Q15
|
20,461
|
+51.9%
|
|
3Q15
|
20,452
|
+101.1%
|
|
2Q15
|
20,406
|
+46.2%
|
|
1Q15
|
13,534
|
+9.5%
|
|
4Q14
|
13,468
|
+38.2%
|
|
3Q14
|
10,171
|
+16.6%
|
|
2Q14
|
13,954
|
+116.1%
|
|
1Q14
|
12,357
|
+52.8%
|
|
4Q13
|
9,743
|
+32.4%
|
|
3Q13
|
8,721
|
+22.0%
|
|
2Q13
|
6,457
|
-10.6%
|
|
1Q13
|
8,089
|
+37.6%
|
|
4Q12
|
7,361
|
-0.7%
|
|
3Q12
|
7,146
|
-20.4%
|
|
2Q12
|
7,223
|
-4.4%
|
|
1Q12
|
5,879
|
-
|
|
4Q11
|
7,412
|
-
|
|
3Q11
|
8,974
|
-
|
|
2Q11
|
7,556
|
-
|